Addyi was initially authorised by the FDA in August 2015 to treat hypoactive sexual want condition (HSDD) in premenopausal Girls. That is just yet another way of claiming it boosts intercourse push (also referred to as libido) in women who've not attained menopause. It was the very first this sort of drug accepted for this use.WHO also includes con